The US Food and Drug Administration (FDA) and the medtech industry have agreed to commitment letter language for the Medical ...
The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
In the latest meeting minutes released by the US Food and Drug Administration (FDA), the agency noted that significant progress has been made toward an agreement with the pharmaceutical industry for ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) revised its compliance program guide (CPG) for preapproval inspections (PAIs) for new drugs. This update emphasizes a risk-based approach to making decisions ...
Notified body association Team-NB has suggested changes to the European Commission’s proposals for risk-adaptive surveillance ...
Industry groups are asking the US Food and Drug Administration (FDA) for greater transparency into its Commissioner's National Priority Voucher (CNPV) pilot, including how the agency intends to ...
The US Food and Drug Administration (FDA) revised its compliance program guide (CPG) for preapproval inspections (PAIs) for new drugs. This update emphasizes a risk-based approach to making decisions ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results